Drägerwerk AG & Co. KGaA (DGWPF)

OTCMKTS · Delayed Price · Currency is USD
55.81
-1.19 (-2.09%)
May 27, 2025, 4:00 PM EDT
9.43%
Market Cap 1.29B
Revenue (ttm) 3.64B
Net Income (ttm) 124.56M
Shares Out n/a
EPS (ttm) n/a
PE Ratio 10.37
Forward PE 10.17
Dividend n/a
Ex-Dividend Date n/a
Volume 100
Average Volume 11
Open 55.81
Previous Close 57.00
Day's Range 55.81 - 55.81
52-Week Range 45.05 - 57.00
Beta 0.33
RSI 99.97
Earnings Date Jul 29, 2025

About Drägerwerk AG & Co. KGaA

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas measurement technology, and comprehensive risk management to customers in industry and mining sectors, as well as public sectors, such as fire departmen... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1889
Employees 16,585
Stock Exchange OTCMKTS
Ticker Symbol DGWPF
Full Company Profile

Financial Performance

In 2024, Drägerwerk AG & Co. KGaA's revenue was 3.37 billion, a decrease of -0.08% compared to the previous year's 3.37 billion. Earnings were 124.41 million, an increase of 12.65%.

Financial numbers in EUR Financial Statements

News

Drägerwerk AG & Co KGaA (DGWPF) Q1 2025 Earnings Call Transcript

Drägerwerk AG & Co KGaA (OTCPK:DGWPF) Q1 2025 Results Conference Call April 30, 2025 8:00 AM ET Company Participants Nikolaus Hammerschmidt - IR Tom Fischler - IR Stefan Dräger - Chief Executive Offic...

4 weeks ago - Seeking Alpha

Drägerwerk AG & Co KGaA (DGWPF) Full Year 2024 Earnings Call Transcript

Drägerwerk AG & Co KGaA (OTCPK:DGWPF) Full Year 2024 Earnings Conference Call March 31, 2025 9:00 AM ET Company Participants Stefan Dräger – Chief Executive Officer Gert-Hartwig Lescow – Chief Financi...

2 months ago - Seeking Alpha